Embria Health Sciences (Embria), a leader in providing safe and science-based dietary supplement ingredients to the global marketplace, and B&D Nutritional Ingredients (B&D), a leader in the distribution of ingredient technologies, announced the signing of an extension to their distribution agreement, granting exclusive rights to market and sell EpiCor® throughout the U.S. The extended distribution agreement builds on an existing collaboration between the two company groups, which resulted in a successful launch of the product in the U.S. and a previous extension of the distribution agreement in 2010. The new agreement extends their partnership into the future.
EpiCor is a unique and natural fermentation ingredient composed of dozens of compounds and metabolites that work together to help strengthen your immune system by balancing immune response. In other words, it acts like a multivitamin for your immune system. Consumers are excited about EpiCor because it provides a range of immune-strengthening benefits tested by science.
“As consumers of all ages increasingly desire a stronger immune system, our customers are looking for proven and consumer-focused ingredients to help their customers,” said Bill Van Dyke, CEO and chairman of B&D Nutritional Ingredients. “EpiCor is clearly a one-of-a-kind, effective ingredient that consumers are adopting into their lifestyle every day and gives our customers an essential and profitable tool for achieving their goals in every environment.”
“B&D has been a critical alliance for us. Partnering with them has enabled us to expand our reach to far more manufacturers,” said Paul Faganel, president of Embria Health Sciences. “We appreciate Bill and his team’s dedication to the industry. His highly competent staff has effectively portrayed EpiCor’s multifaceted benefits to the marketplace. Our partnership with B&D reinforces the value EpiCor delivers to dietary supplement manufacturers to create products proven to strengthen the immune system, which is a highly desirable consumer benefit.”
To learn more about EpiCor, visit EpiCorImmune.com. B&D and Embria will be exhibiting (booth nos. 847 and 534, respectively) at Ingredient Marketplace, June 2 and 3 at Jacob K. Javits Convention Center in New York.